期刊文献+

Survivin启动子驱动LRIG1基因表达的重组腺病毒对人膀胱癌细胞T24侵袭能力的影响 被引量:1

Effect of recombinant adenoviral vector carrying LRIG1 gene driven by Survivin promoter on the invasion of human bladder cancer cells T24 in vitro
下载PDF
导出
摘要 目的以Survivin启动子驱动LRIG1基因表达的重组腺病毒Ad-Surp-LRIG1转染人膀胱癌细胞系T24细胞,观察其对T24细胞侵袭能力的影响。方法 Ad-Surp-LRIG1转染T24细胞,用RT-PCR和Westernblot检测细胞中LRIG1的表达水平,并采用Transwell小室测定转染后细胞侵袭能力的变化。结果 Ad-Surp-LRIG1转染人膀胱癌T24细胞后,与对照组和空白对照组相比,体外侵袭实验显示实验组细胞的侵袭能力明显下降。LRIG1的mRNA和蛋白表达水平明显升高,而EGFR的mRNA和蛋白表达水平则显著降低(P<0.01)。结论 Survivin启动子驱动LRIG1基因表达的重组腺病毒Ad-Surp-LRIG1能够在T24细胞中有效表达,并显著抑制T24细胞的侵袭能力。 Objective To study the effect of invasion ability of the bladder cancer cell line T24 after transfeeted with recombinant adenoviral vector carrying LRIG1 gene driven by Survivin promot- er (Ad-Surp-LRIG1). Methods Ad-Surp-LRIG1 was infected into bladder cancer cells T24, the expression of mRNA and protein of LRIG1 and EGFR were detected by RT-PCR and Western blot. And Transwell Chamber were used to assay the change of invasion ability of transfected cell lines in vitro. Results After T24 cell line was infected with Ad-Surp-LRIG1, the invasion ability de- creased significantly, the expression of mRNA and protein of LRIG1 were obviously up-regulated and those of EGFR were down-regulated (P〈0. 01). Conclusions Ad-Surp-LRIG1 can signifi- cantly inhibit the invasion ability of T24 cell line.
出处 《现代泌尿生殖肿瘤杂志》 2013年第3期162-166,共5页 Journal of Contemporary Urologic and Reproductive Oncology
基金 浙江省自然科学基金项目(Y2090805和LY12H05002)
关键词 膀胱肿瘤 LRIG1基因 肿瘤侵袭 腺病毒载体 Urinary bladder neoplasms LRIG1 gene Neoplasm invasiveness Adenovi- rus vector
  • 相关文献

参考文献18

  • 1Holmlund C,Nilsson J, Guo D,et al. Characterization andtissue-specific expression of human LRIG2[J]. Gene,2004,332(5):35-43.
  • 2Hedman H,Nilsson J,Guo D,et al. Is LRIG1 a tumoursuppressor gene at chromosome 3pl4. 3. [J]. Acta Oncol,2002,41(4):352-354.
  • 3严泽军,程跃,蒋军辉,胡嘉盛,施小东,黄坚成.Survivin启动子驱动的LRIG1基因重组腺病毒载体的构建及鉴定[J].现代实用医学,2012,24(2):133-135. 被引量:3
  • 4严泽军,程跃,蒋军辉,胡嘉盛,施小东,黄坚成.Survivin启动子驱动LRIG1基因表达的重组腺病毒对人膀胱癌细胞BIU87生长的影响[J].中国中西医结合外科杂志,2012,18(4):375-379. 被引量:1
  • 5叶飞,郭东升,牛洪泉,陶胜中,欧一博,卢运萍,雷霆.LRIG1cDNA诱导人胶质瘤细胞系H4凋亡的分子机制[J].癌症,2004,23(10):1149-1154. 被引量:19
  • 6Stenzl A, Witjes JA,Comperat E,et al. Guidelines on blad-der cancer muscle-invasive and metastatic [ EB]. EuropeanAssociation of Urology,2012 [2013-01-25]. http://www.uroweb. org/gls/pdf/07_Bladder%20Cancer_LR%20H. pdf.
  • 7Hoon D, Kitago M, Kim J , et al. Molecular mechanisms ofmetastasis[j]. Cancer Metastasis Rev,2006 ,25(2) : 203-220.
  • 8Guo DS, Holmlund C, Henriksson R, et al. The LRIG genefamily has three vertebrate paralogs widely expressed in hu-man and mouse tissues and a homolog in Ascidiacea[j3. Ge-nomics,2004 ,84(1):157-165.
  • 9Jensen KB, Collins CA,Nascimento E, et al. Lrigl expres-sion defines a distinct multipotent stem cell population inmammalian epidermis[J]. Cell Stem CeU,2009,4 ( 5) : 427-439.
  • 10Stutz MA, Shattuck DL, Laederich MB, et al. LRIG1 nega-tively regulates the oncogenic EGF receptor mutant EGFRvI-IICJD. Oncogene,2008*27(43):5741-5752.

二级参考文献41

  • 1叶飞,郭东升,易伟,牛洪泉,舒凯,万锋,卢运萍,雷霆.过度表达LRIG1基因逆转人胶质瘤侵袭性的机制[J].中华实验外科杂志,2005,22(2):200-202. 被引量:26
  • 2王亚轩,蔡文清,黎玮,张勇,白志杰,吴建辉.人端粒酶逆转录酶启动子调控腺病毒介导的胸苷激酶基因治疗膀胱癌的实验研究[J].中华泌尿外科杂志,2005,26(4):229-232. 被引量:14
  • 3杨为民,严泽军,叶章群,郭东升,蔡建良.抑癌基因LRIG1对膀胱癌细胞BIU87生物学特性的影响[J].中华实验外科杂志,2005,22(12):1543-1545. 被引量:23
  • 4叶章群,严泽军,杨为民,郭东升.LRIG1基因对膀胱癌细胞侵袭力的影响[J].中华外科杂志,2007,45(4):258-261. 被引量:13
  • 5Besson A, Yong VW. Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas [J]. J Neurooncol,2001, 51(3): 245 7264.
  • 6Ghiglione C, Carraway KL 3rd, Amundadottir LT, et at. The transmembrane molecule kekkon I acts in a feedback loop to negatively regulate the activity of the Drosophila EGF receptor during oogenesis [J]. Cell, 1999, 96 (6): 847-856.
  • 7Nilsson J, Vallbo C, Guo D, et al. Cloning, characterization, and expression of human LIGI [J] . Biochem Biophys Res Commun,2001,284(5): 1155-1161.
  • 8Nilsson J, Starefeldt A, Henriksson R, et al. LRIG1 protein in human cells and tissues [J] . Cell Tissue Res, 2003, 312(1):65-71.
  • 9Hedman H, Nilsson J, Guo D, et al. Is LRIG1 a tumour suppressor gene at ebromosome 3p14. 3? [J] . Acta Oncol, 2002, 41(4):352-354.
  • 10Thomasson M, Hedman H, Guo D, et al. LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT-PCR and immunohistochemical analysis [J] . Br J Cancer,2003,89(7): 1285-1289.

共引文献26

同被引文献20

  • 1朱宏建,王发强,曾祥福,魏守顺,郭应禄.人UroplakinⅡ启动子用于靶向性基因治疗膀胱癌的实验研究[J].中华泌尿外科杂志,2006,27(S1):18-21. 被引量:2
  • 2Siegel R,Naishadham D,Jemal A.Cancer statistics,2012[J].CA Cancer J Clin,2012,62(1):10-29.
  • 3Herr HW,Wartinger DD,Fair WR,et al.Bacillus Calmette-Guerin therapy for superficial bladder cancer:a 10 year followup[J].J Urol,1992,147(4):1020-1023.
  • 4Voutsinas GE,Stravopodis DJ.Molecular targeting and gene delivery in bladder cancer therapy[J].J BUON,2009,14(Suppl 1):S69-S78.
  • 5Kanerva A,Hemminki A.Adenoviruses for treatment of cancer[J].Ann Med,2005,37(1):33-43.
  • 6Wildner O,Morris JC.The role of the EIB 55 k Da gene product in oncolytic adenoviral vectors expressing herpes simplex Virus-tk:assessment of antitumor efficacy and toxicity[J].Cancer Rcs,2000,60(15):4167-4174.
  • 7Ries S,Korn WM.ONYX-015:mechanism of action and clinical potential of a replication—selective adenovirus[J].Br J Cancer,2002,86(1):5-11.
  • 8Kohno S,Luo C,Goshima F,et al.Herpes simplex virus type 1mutant HF10 oncolytic viral therapy for bladder cancer[J].Urology,2005,66(5):1116-1121.
  • 9Shirakawa T,Hamada K,Zhang Z,et al.A COX-2 promoter based replication selective adenoviral vector to target the COX-2 expressing human bladder cancer cells[J].Clin Cancer Res,2004,10(13):4342-4348.
  • 10Melquist JJ,Kacka M,Malaeb BS,et al.Conditionally replicating adenovirus-mediated gene therapy in bladder cancer:an orthotopic in vivo model[J].Urol Oncol,2006,24(4):362-371.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部